U.S., Jan. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07367399) titled 'Acute Myocardial Infarction Clinical Intelligent Decision Support System' on Jan. 18.

Brief Summary: Acute Myocardial Infarction (AMI) remains the leading cause of cardiovascular mortality globally. In China, while the incidence of AMI is escalating at an annual rate of 5.2%, significant clinical challenges persist: diagnostic delays in primary care facilities exceed 40%, and the "Door-to-Balloon" (D2B) compliance rate in tertiary hospitals stagnates at a mere 65%. These figures underscore systemic deficiencies, including inefficient emergency response, regional resource disparities, and fragmented longitudinal care. Although Large ...